From§Each
WEDNESDAY, 9 SEPTEMBER 2026 — THE EARLY EVENING EDITION
Health
Page H4
Withdrawn from the Formulary
The research this country decided it could do without.
- ~$500MThe mRNA wind-down: 22 vaccine-development projects terminated — Bird-flu and pandemic platforms at Moderna, Pfizer and Emory among them. The department's phrase: a "coordinated wind-down." (Aug 2025)
- $766MModerna's pandemic bird-flu vaccine contract — Canceled the same week the company reported positive interim trial results. (May 2025)
- 2,291 grants, $2.45BNIH research grants terminated in 2025 — The peer-reviewed count. Hundreds were reinstated by one court and re-terminated when a higher one let the cuts resume. (2025)
- $11.4BCOVID-era grants to state and local health departments — Moved to claw back — "the COVID-19 pandemic is over." A federal judge blocked it, but only for the states that sued. (Mar 2025)
- 86% terminatedUSAID's global-health awards — 5,341 of roughly 6,200 awards. The Lancet's projection — and it is a projection — runs to millions of additional deaths by 2030. (Apr 2025)
- 15 hospitalsThe pediatric brain-tumor trial network — The consortium that has run early-phase childhood brain-cancer trials since 1999 says it "will cease to exist"; the NCI says the work moves to a broader network. Its trials closed to new enrollment either way. (2026)
Each withdrawal dated and priced from the agency’s own announcement or the reporting that counted it.
Dispensary verified 24 August 2026. Symptoms move faster than print; the next sweep advances the label.